A p53-independent pathway for induction of p21(waf1cip1) and concomitant G1 arrest in UV-irradiated human skin fibroblasts

Cancer Research

Volumn 57, Issue 16, 1997, Pages 3390-3394

  Loignon, Martin ^a   Fetni, Raouf ^a   Gordon, Alasdair J E ^a   Drobetsky, Elliot A ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLASTOGEN; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P21; PROTEIN P53;

ARTICLE; CARCINOGENESIS; CELL CULTURE; CELL CYCLE G1 PHASE; CELL GROWTH; DNA DAMAGE; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL; SKIN FIBROBLAST; ULTRAVIOLET RADIATION;

ANEUPLOIDY; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA DAMAGE; FIBROBLASTS; G1 PHASE; HUMANS; POLYPLOIDY; S PHASE; SKIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030761736     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. 1 arrest in human cancer cells. Cancer Res., 55: 5187-5190, 1995.
2. 1 arrest. Cell, 76: 1013-1023, 1994.
3. 1 arrest is selectively mediated by the p53-Waf1Cip1 pathway in human thyroid cells. Cancer Res., 55: 2075-2080, 1995.
4. 1 arrest and apoptosis. Cancer Res., 54: 1169-1174, 1994.
5. waf1cip1 response to genotoxic agents in wild-type TP53 expressing breast primary tumours. Oncogene, 14: 45-52, 1997.
6. 1 arrest in established human tumour lines. Oncogene, 11: 1885-1892, 1995.
7. 1 arrest involves pRb-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA, 91: 5320-5234, 1994.
8. Waga, S., Hannon, G. J., Beach, D., and Stillman, B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature (Lond.), 369: 574-578, 1994.
9. 1 arrest and apoptosis. Proc. Natl. Acad. Sci. USA, 92: 9019-9023, 1995.
10. Koh, J., Enders, G. H., Dynlacht, B. D., and Harlow, E. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature (Lond.), 375: 506-510, 1995.
11. Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., and Bartek, J. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16, Nature (Lond.), 375: 503-506, 1995.
12. Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., and Jacks, T. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev., 9: 935-944, 1995.
13. Yuxin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., and Wahl, G. M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell, 70: 937-948, 1992.
14. Zhan, Q., Carrier, F., and Fornace, A. J., Jr. Induction of cellular p53 activity by DNA damaging agents and growth arrest. Mol. Cell. Biol., 13: 4242-4250, 1993.
15. Bischoff, F., Yim, S. O., Pathak, S., Grant, G., Siciliano, M. J., Giovanella, B. C., Strong, L. C., and Tainsky, M. A. Spontaneous immortalization of normal fibroblasts form patients with Li-Fraumeni cancer syndrome. Cancer Res., 50: 7979-7984, 1990.
16. Liu, P. K., Kraus, E., Wu, T. A., Strong, L. C., and Tainsky, M. A, Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations. Oncogene, 12: 2267-2278, 1996.
17. Little, J. B., and Nagasawa, H. Effect of confluent holding on potentially lethal damage repair, cell cycle progression, and chromosomal aberrations in human normal and ataxia-telangiectasia fibroblasts. Radial. Res., 101: 81-93, 1985.
18. 1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev., 8: 2540-2551, 1994.
19. Zeng, Y. X., and El-Deiry, W. S. Regulation of p21(Waf1/Cip1) expression by P53-independent pathways. Oncogene, 12: 1557-1564, 1966.
20. Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E., and Givol, D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res., 54: 3391-3395, 1994.
21. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev., 10: 142-153, 1966.
22. Sheikh, M. S., Li, X. S., Chen, J. C., Shao, Z. M., Ordonez, J. V., and Fontana, J. A. Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene, 9: 3407-3415, 1994.
23. Gartenhaus, R. B., Wang, P., and Hoffmann, P. Induction of the WAF1/CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with adriamycin by using a p53-independent pathway. Proc. Natl. Acad. Sci. USA, 93: 265-268, 1996.
24. Johnson, M., Dimitrov, D., Vojta, P. J., Barrett, J. C., Noda, A., Pereira-Smith, O. M., and Smith, J. R. Evidence for a p53-independent pathway for upregulation of SDI1/CIP1/WAF1/p21 RNA in human cells. Mol. Carcinog., 11: 59-64, 1994.
25. Gujuluva C. N., Baek, J. H., Shin, K. H., Cherrick, H. M., and Park, N. H. Effect of UV-irradiation on cell cycle, viability and the expression of p53, gadd153 and gadd45 genes in normal and HPV-immortalized human oral keratinocytes. Oncogene, 9: 1819-1827, 1994.
26. Haapajarvi, T., Kivinen, L., Pitkanen, K., and Laiho, M. Cell cycle dependent effects of u.v.-radiation on p53 expression and retinoblastoma protein phosphorylation. Oncogene, 11: 151-159, 1995.
27. 2 checkpoint in rodent cells. Mol. Cell Biol., 15: 3722-3730, 1995.
28. Liu, M., Dhanwada, K. R., Birt, D. F., Hecht, S., and Pelling, J. C. Increase in p53 protein half-life in mouse keratinocytes following UV-B irradiation. Carcinogenesis (Lond.), 15: 1089-1092, 1994.
29. Liu, M., and Pelling, J. C. UV-B/A irradiation of mouse keratinocytes results in p53-mediated WAF1/CIP1 expression. Oncogene, 10: 1955-1960, 1995.
30. 1 and S phase checkpoints. Oncogene, 12: 1387-1396, 1996.
31. waf-1/SDI-1/Cip-1 protein. Cancer Res., 55: 4047-4052, 1995.
32. Tyrrell, R. M. Activation of gene expression by the UV component of sunlight: from models to reality. Bioessays, 18: 139-148, 1996.
33. Friedberg, E. C., Walker, G. C., and Siede, W. (eds.) DNA Repair and Mutagenesis. Washington, D. C.: American Society for Microbiology Press, 1995.
34. Drobetsky, E. A., Moustacchi, E., Glickman, B. W., and Sage, E. The mutational specificity of simulated sunlight at the aprt locus in rodent cells. Carcinogenesis (Lond.), 15: 1577-1583, 1994.
35. Brash, D. E., Rudolph, J. A., Simon, J. A., Lin, A., McKenna, G. J., Baden, H. P., Halperin, A. J., and Ponten, J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA, 88: 10124-10128, 1991.
36. Ziegler, A., Leffell, D. J., Kunala, S., Sharma, H. W., Gailani, M., Simon, J. A., Halperin, A. J., Baden, H. P., Shapiro, P. E., Bale, A. E., and Brash, D. E. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc. Natl. Acad. Sci. USA, 90: 4216-4220, 1993.
37. Mitchell, D. L. The relative cytotoxicity of (6-4) photoproducts and cyclobutane dimers in mammalian cells. Photochem, Photobiol., 48: 51-57, 1988.
38. Kraemer, K. H. Sunlight and skin cancer: another link is revealed. Proc. Natl. Acad. Sci. USA, 94: 11-14, 1997.
39. Ziegler, A., Jonason, A. S., Leffell, D. J., Simon, J. A., Sharma, H. W., Kimmelman, J., Remington, L., Jacks, T., and Brash, D. E. Sunburn and p53 in the onset of skin cancer. Nature (Lond.), 372: 773-776, 1994.
40. Ford, J. M., and Hanawalt, P. C. Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc. Natl. Acad. Sci. USA, 92: 8876-8880, 1996.